P.V. Suryakiran

1.7k citations

32 papers · 1.1k indexed · h-index 21

Hepatology top 2%
- Hepatitis Viruses Studies and Epidemiology 15
Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology 19
Cardiology and Cardiovascular Medicine top 5%
- Viral Infections and Immunology Research 15
Animal Science and Zoology top 5%
Epidemiology top 10%
- Hepatitis B Virus Studies 12
- Cervical Cancer and HPV Research 10
Surgery
- Genital Health and Disease 6
Genetics
- Virus-based gene therapy research 3
Biomedical Engineering
- Biomedical and Engineering Education 2

Co-authors: Igor Smolenov Htay Htay Han Frank Struyf Florence Thomas Tino F. Schwarz L.J. van Doorn Nicolas Folschweiller Karin Schulze
Cited by: Hepatology Infectious Diseases Cardiology and Cardiovascular Medicine
Journals: The Journal of Infectious Diseases (1 paper)Vaccine (9 papers)BJOG An International Journal of Obstetrics & Gynaecology (1 paper)
Partner nations: Belgium India United Kingdom

In The Last Decade

P.V. Suryakiran

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by P.V. Suryakiran

Since Specialization

Citations

This map shows the geographic impact of P.V. Suryakiran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.V. Suryakiran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.V. Suryakiran more than expected).

Fields of papers citing papers by P.V. Suryakiran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.V. Suryakiran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.V. Suryakiran. The network helps show where P.V. Suryakiran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P.V. Suryakiran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.V. Suryakiran Line = papers co-authored together P.V. Suryakiran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial Vaccine ·Ting Fan Leung,Anthony Pak‐Yin Liu,Fong Seng Lim,Franck Thollot,Helen May Lin Oh,Bee Wah Lee,Lars Rombo,Ngiap Chuan Tan,Roman Rouzier,Stéphanie De Simoni,P.V. Suryakiran,Marjan Hezareh,Florence Thomas,Nicolas Folschweiller,Frank Struyf	2017	22
2	Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study Human Vaccines & Immunotherapeutics ·Barbara Romanowski,Tino F. Schwarz,Linda Ferguson,Klaus Peters,Marc Dionne,Ulrich Behre,Karin Schulze,Peter Hillemanns,P.V. Suryakiran,Florence Thomas,Frank Struyf	2015	70
3	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial Human Vaccines & Immunotherapeutics ·Ting Fan Leung,Anthony Pak‐Yin Liu,Fong Seng Lim,Franck Thollot,Helen May Lin Oh,Bee Wah Lee,Lars Rombo,Ngiap Chuan Tan,Roman Rouzier,Damien Friel,Benoit De Muynck,Stéphanie De Simoni,P.V. Suryakiran,Marjan Hezareh,Nicolas Folschweiller,Florence Thomas,Frank Struyf	2015	41
4	Long-term Immunogenicity and Safety of the HPV-16/18 AS04-adjuvanted Vaccine in 10- to 14-year-old Girls The Pediatric Infectious Disease Journal ·Tino F. Schwarz,Li‐Min Huang,Tzou‐Yien Lin,Christoph Wittermann,Falko Panzer,Alejandra Valencia,P.V. Suryakiran,Lan Lin,Dominique Descamps	2014	21
5	Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination Human Vaccines & Immunotherapeutics ·Barbara Romanowski,Tino F. Schwarz,Linda M. Ferguson,Murdo Ferguson,Klaus Peters,Marc Dionne,Karin Schulze,Brian Ramjattan,Peter Hillemanns,Ulrich Behre,P.V. Suryakiran,Florence Thomas,Frank Struyf	2014	85
6	Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial Vaccine ·YL Lau,E. Anthony S. Nelson,Kin-Hung Poon,Paul K.S. Chan,Susan S. Chiu,R Y T Sung,Chi Wai Leung,Daniel K. Ng,Yee Man,Y. Chan,Tsz Leung Lee,Joyce Tang,Mike Yat Wah Kwan,Patricia Ip,M. Ho,Lai‐Wah Eva Fung,Haïwen Tang,P.V. Suryakiran,Htay Htay Han,Hans L. Bock	2013	23
7	Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth Journal of the Formosan Medical Association ·Chun‐Yi Lu,Luan‐Yin Chang,Pei‐Lan Shao,P.V. Suryakiran,Htay-Htay Han,Li‐Min Huang	2013	2
8	Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: A randomized, double-blind, placebo-controlled, phase IV study Human Vaccines & Immunotherapeutics ·(unknown),Chong-Woo Bae,Kyung‐Yil Lee,Moon Sung Park,Young Youn Choi,Kwang Nam Kim,Jong Duck Kim,Won-Soon Park,Jong-Beom Sin,Ellen Ai‐Rhan Kim,Sang-Geel Lee,Chun Soo Kim,Sung‐Ho Cha,Young Jin Hong,Son Moon Shin,Gyu Hong Shim,Kyong Min Choi,Jun Yang,Aixue Liu,P.V. Suryakiran,Htay Htay Han	2012	21
9	Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial BMC Infectious Diseases ·A. Duncan Steele,Kathleen M. Neuzil,Nigel A. Cunliffe,Shabir A. Madhi,P.K. Bos,Bagrey Ngwira,Desirée Witte,Stacy Todd,Cheryl Louw,Mari Kirsten,S Aspinall,L.J. van Doorn,Alain Bouckenooghe,P.V. Suryakiran,Htay Htay Han	2012	114
10	Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants The Pediatric Infectious Disease Journal ·Félix Omeñaca,J Sarlangue,Leszek Szenborn,Marta Nogueira,P.V. Suryakiran,Igor Smolenov,Htay Htay Han	2012	50
11	Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America The Pediatric Infectious Disease Journal ·Miguel Tregnaghi,Héctor Abate,Alejandra Valencia,Pío López,Themis Reverbel da Silveira,Luis Rivera,Doris Maribel Rivera Medina,Xavier Sáez‐Llorens,Silvia Elena González Ayala,Tirza De León,Leen‐Jan van Doorn,Maria del Pilar Rubio,P.V. Suryakiran,Javier M. Casellas,Eduardo Ortega‐Barría,Igor Smolenov,Htay-Htay Han	2011	47
12	Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life Vaccine ·Naohisa Kawamura,Yasunobu Tokoeda,Miho Oshima,Hiroyasu Okahata,Hiroyuki Tsutsumi,L.J. van Doorn,Hisao Muto,Igor Smolenov,P.V. Suryakiran,Htay Htay Han	2011	64
13	Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006–2007 Vaccine ·Đặng Đức Anh,Celia Carlos,Danielle Thiem,Yanee Hutagalung,Salvacion Gatchalian,H.L. Bock,Igor Smolenov,P.V. Suryakiran,Htay Htay Han	2011	30
14	Rotarix in Developing Countries: Paving the Way for Inclusion in National Childhood Immunization Programs in Africa The Journal of Infectious Diseases ·Robert Pawinski,S. Debrus,A. Delem,Igor Smolenov,P.V. Suryakiran,Htay Htay Han	2010	10
15	Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study Vaccine ·Kong Boo Phua,Filip Lim,YL Lau,E. Anthony S. Nelson,Li‐Min Huang,Seng Hock Quak,B.W. Lee,Yee Leong Teoh,Haïwen Tang,Irving Charles Boudville,Lidia Oostvogels,P.V. Suryakiran,Igor Smolenov,Hongying Han,H.L. Bock	2009	123
16	Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age Vaccine ·Khalequ Zaman,David A. Sack,Mohammad Yunus,Shams El Arifeen,Goutam Podder,Tasnim Azim,Stephen P. Luby,Robert F. Breiman,Kathleen M. Neuzil,Sanjoy Datta,A. Delem,P.V. Suryakiran,H.L. Bock	2009	90
17	Human Rotavirus Vaccine RIX4414 (Rotarix™) Is Highly Efficacious in Infants from Asia During the First Two Years of Life International Journal of Infectious Diseases ·Kong Boo Phua,Filip Lim,YL Lau,E. Anthony S. Nelson,Li‐Min Huang,Seng Hock Quak,B.W. Lee,Yee Leong Teoh,Haïwen Tang,H.L. Bock,P.V. Suryakiran,Igor Smolenov,Htay Htay Han	2008	9
18	Immunogenicity of an Oral Polio Vaccine is Unaffected when Co-Administered with a Human Rotavirus Vaccine RIX4414 (Rotarix™) in Latin America International Journal of Infectious Diseases ·Pío López,Héctor Abate,Tirza De León,Miguel Tregnaghi,Alejandra Valencia,Themis Reverbel da Silveira,Luis Rivera,Doris Maribel Rivera-Medina,S.A. Gonzalez,Eduardo Ortega‐Barría,José María Casellas,P.V. Suryakiran,Igor Smolenov,Hongying Han	2008	2
19	Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants International Journal of Infectious Diseases ·Đặng Đức Anh,Vũ Đình Thiểm,Yanee Hutagalung,H.L. Bock,P.V. Suryakiran,A. Delem,Hongying Han	2008	5
20	Immunogenicity of The Oral Live Attenuated Human Rotavirus Vaccine RIX4414 (Rotarix™) Oral Suspension (Liquid Formulation) Co-administered with Childhood Vaccinations in Panama International Journal of Infectious Diseases ·Andrés Andrade Velásquez,Elena Domı́nguez,P.V. Suryakiran,A. Delem,Eduardo Ortega‐Barría,Hongying Han	2008	2

About P.V. Suryakiran

P.V. Suryakiran is a scholar working on Hepatology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (19 papers), Viral Infections and Immunology Research (15 papers), Hepatitis Viruses Studies and Epidemiology (15 papers), Hepatitis B Virus Studies (12 papers), Cervical Cancer and HPV Research (10 papers), Genital Health and Disease (6 papers), Virus-based gene therapy research (3 papers) and Biomedical and Engineering Education (2 papers). The work is most often cited by research in Hepatology (420 citations), Infectious Diseases (681 citations) and Cardiology and Cardiovascular Medicine (457 citations). P.V. Suryakiran has collaborated with scholars based in Belgium, India and United Kingdom. Frequent co-authors include Igor Smolenov, Htay Htay Han, Frank Struyf, Florence Thomas, Tino F. Schwarz, L.J. van Doorn, Nicolas Folschweiller, Karin Schulze, Li‐Min Huang and Kathleen M. Neuzil. Their work appears in journals such as The Journal of Infectious Diseases, Vaccine and BJOG An International Journal of Obstetrics & Gynaecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact